变形小细胞肺癌的风景和治疗选择
Yijun Gu1, Claudia A Benavente1,2,3
1Department of Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA.
Journal of clinical medicine
|June 19, 2024
概括
小细胞肺癌 (SCLC) 是一种复杂的恶性瘤,有多种不同的亚型. 了解这些亚型及其基因组景观对于开发超越当前化疗和免疫检查点抑制剂的新疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有不良预后的侵袭性神经内分泌瘤.
- 目前对SCLC的治疗方法,包括化疗和免疫检查点抑制剂,有效性有限.
- 在SCLC中高瘤异质性有助于患者的反应和早期复发的多样化.
研究的目的:
- 审查目前对SCLC基因组景观的理解.
- 探索不同SCLC分子亚型的特征和治疗脆弱性.
- 突出SCLC临床开发中的有希望的新型治疗剂.
主要方法:
- 文献综述,整合了关于SCLC基因组学的最新发现.
- 基于转录因子和免疫基因表达的分子亚型的分析.
- 目前正在进行SCLC临床试验的药物数据的汇编.
主要成果:
- 在SCLC中表现出显著的内和间异质性.
- 分子亚型 (例如ASCL1,NEUROD1,POU2F3,YAP1) 显示出不同的分化和免疫特征.
- 一些新的治疗标和药物正在调查中,显示了改善SCLC治疗的前景.
结论:
- 根据SCLC分子亚型定制治疗策略至关重要.
- 对SCLC的基因组和免疫格局的进一步研究将推动有效疗法的开发.
- 临床试验中的新兴药物为患有这种具有挑战性的癌症的患者提供了新的希望.
更多相关视频
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.2K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
